The deal is likely to face antitrust scrutiny despite minimal geographic overlap between Amedisys and existing UnitedHealth home health business LHC Group, analysts said.
The deal is likely to face antitrust scrutiny despite minimal geographic overlap between Amedisys and existing UnitedHealth home health business LHC Group, analysts said.